ENvue Medical (FEED) Income from Continuing Operations (2014 - 2026)
ENvue Medical's (FEED) quarterly Income from Continuing Operations came in at 3822000.0 in Q1 2026, down 104.17% year-on-year from 91728000.0 in Q1 2025, and up 70.26% on a QoQ basis from 12852000.0 in Q4 2025.
ENvue Medical (FEED) Income from Continuing Operations (2014 - 2026) Analysis & Trends
ENvue Medical (FEED) has 13 years of Income from Continuing Operations data on file, last reported at 3822000.0 in Q1 2026.
- On a quarterly basis, Income from Continuing Operations fell 104.17% year-over-year to 3822000.0 in Q1 2026; TTM through Mar 2026 was 20135000.0, a 1346.48% decrease from a year earlier, with the FY2025 full-year figure at 18185000.0, down 16737.96% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 3822000.0, up from 12852000.0 in the prior quarter.
- Over the last five years, Income from Continuing Operations for FEED reached as high as 2166000.0 in Q4 2024 and fell as low as 12852000.0 in Q4 2025.
- Historically, Income from Continuing Operations has averaged 1839647.06 across 5 years, with a median of 1074000.0 in 2023.
- Across the five-year window, Income from Continuing Operations jumped 366.42% in 2024 and sank 693.35% in 2025, its largest moves.
- Year by year, Income from Continuing Operations stood at 2059000.0 in 2022, then soared by 60.51% to 813000.0 in 2023, then soared by 366.42% to 2166000.0 in 2024, then sank by 693.35% to 12852000.0 in 2025, then jumped by 70.26% to 3822000.0 in 2026.
- Per Business Quant data, the three most recent Income from Continuing Operations figures were 3822000.0 in Q1 2026, 12852000.0 in Q4 2025, and 510000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | ENvue Medical | 10,254.30 | -2.25 Mn | -55,000.00 | -3.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.82 Mn |
| Dec 31, 2025 | -12.85 Mn |
| Sep 30, 2025 | 510,000.00 |
| Jun 30, 2025 | -3.97 Mn |
| Mar 31, 2025 | -1.87 Mn |
| Dec 31, 2024 | 2.17 Mn |
| Sep 30, 2024 | -998,000.00 |
| Jun 30, 2024 | -688,000.00 |
| Mar 31, 2024 | -588,000.00 |
| Dec 31, 2023 | -813,000.00 |
| Sep 30, 2023 | -727,000.00 |
| Jun 30, 2023 | -1.07 Mn |
| Mar 31, 2023 | -1.10 Mn |
| Dec 31, 2022 | -2.06 Mn |
| Sep 30, 2022 | -955,000.00 |
| Jun 30, 2022 | -1.30 Mn |
| Mar 31, 2022 | -1.13 Mn |
| Dec 31, 2021 | 26.11 Mn |
| Sep 30, 2021 | -6.68 Mn |
| Jun 30, 2021 | -216,000.00 |